ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$190.36−4.80 (-2.46%)
Close on Nov 19, 2026Market cap $14.58BP/E 32.8Yield –
ICON free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ICON's free cash flow for the twelve months ending Sep 30, 2026 was $857.06M, down 11.1% year over year. For fiscal 2025 it was $861.99M, down 22.9% from the year before. Over ten years it grew 14.2% a year on average. The highest annual figure on record is $1.12B in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $861.99M | -22.9% |
| FY2024 | Dec 31, 2024 | $1.12B | +9.6% |
| FY2023 | Dec 31, 2023 | $1.02B | +142.3% |
| FY2022 | Dec 31, 2022 | $421.16M | -42.7% |
| FY2021 | Dec 31, 2021 | $735.39M | +39.5% |
| FY2020 | Dec 31, 2020 | $527.15M | +41.1% |
| FY2019 | Dec 31, 2019 | $373.59M | +69.6% |
| FY2018 | Dec 31, 2018 | $220.24M | -34.9% |
| FY2017 | Dec 31, 2017 | $338.37M | +56.2% |
| FY2016 | Dec 31, 2016 | $216.60M | -5.6% |
| FY2015 | Dec 31, 2015 | $229.34M | +68.3% |
| FY2014 | Dec 31, 2014 | $136.26M | -28.9% |
| FY2013 | Dec 31, 2013 | $191.74M | +132.0% |
| FY2012 | Dec 31, 2012 | $82.64M | – |
| FY2011 | Dec 31, 2011 | -$15.09M | -126.7% |
| FY2010 | Dec 31, 2010 | $56.48M | -74.5% |
| FY2009 | Dec 31, 2009 | $221.28M | +1551.3% |
| FY2008 | Dec 31, 2008 | $13.40M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $307.15M | -8.0% |
| Q2 FY2026 | Jun 30, 2026 | $238.85M | +109.7% |
| Q1 FY2026 | Mar 31, 2026 | $136.24M | -43.1% |
| Q4 FY2025 | Dec 31, 2025 | $174.83M | -36.9% |
| Q3 FY2025 | Sep 30, 2025 | $333.90M | -7.1% |
| Q2 FY2025 | Jun 30, 2025 | $113.92M | -37.5% |
| Q1 FY2025 | Mar 31, 2025 | $239.33M | -20.2% |
| Q4 FY2024 | Dec 31, 2024 | $277.03M | -28.5% |
| Q3 FY2024 | Sep 30, 2024 | $359.34M | +15.0% |
| Q2 FY2024 | Jun 30, 2024 | $182.30M | +6.1% |
| Q1 FY2024 | Mar 31, 2024 | $299.92M | +101.6% |
| Q4 FY2023 | Dec 31, 2023 | $387.42M | – |
| Q3 FY2023 | Sep 30, 2023 | $312.42M | +77.0% |
| Q2 FY2023 | Jun 30, 2023 | $171.75M | +11.6% |
| Q1 FY2023 | Mar 31, 2023 | $148.76M | -28.2% |
| Q4 FY2022 | Dec 31, 2022 | -$116.44M | -148.1% |
| Q3 FY2022 | Sep 30, 2022 | $176.47M | -35.7% |
| Q2 FY2022 | Jun 30, 2022 | $153.84M | +33.2% |
| Q1 FY2022 | Mar 31, 2022 | $207.28M | +100.8% |
| Q4 FY2021 | Dec 31, 2021 | $242.14M | +32.6% |
| Q3 FY2021 | Sep 30, 2021 | $274.56M | +161.2% |
| Q2 FY2021 | Jun 30, 2021 | $115.49M | +6.9% |
| Q1 FY2021 | Mar 31, 2021 | $103.22M | -21.5% |
| Q4 FY2020 | Dec 31, 2020 | $182.56M | +43.3% |
| Q3 FY2020 | Sep 30, 2020 | $105.10M | -28.5% |
| Q2 FY2020 | Jun 30, 2020 | $108.04M | +835.2% |
| Q1 FY2020 | Mar 31, 2020 | $131.45M | +50.1% |
| Q4 FY2019 | Dec 31, 2019 | $127.43M | +211.9% |
| Q3 FY2019 | Sep 30, 2019 | $147.02M | +25.7% |
| Q2 FY2019 | Jun 30, 2019 | $11.55M | -61.9% |
| Q1 FY2019 | Mar 31, 2019 | $87.60M | +172.4% |
| Q4 FY2018 | Dec 31, 2018 | $40.85M | -51.9% |
| Q3 FY2018 | Sep 30, 2018 | $116.94M | +16.6% |
| Q2 FY2018 | Jun 30, 2018 | $30.29M | +1270.5% |
| Q1 FY2018 | Mar 31, 2018 | $32.16M | -78.7% |
| Q4 FY2017 | Dec 31, 2017 | $84.87M | -27.4% |
| Q3 FY2017 | Sep 30, 2017 | $100.26M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.21M | – |
| Q1 FY2017 | Mar 31, 2017 | $151.03M | – |
| Q4 FY2016 | Dec 31, 2016 | $116.91M | – |
See a number that looks wrong?